The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Colorectal Cancer in Inflammatory Bowel Disease
Open accessAbstract
Patients with inflammatory bowel disease (IBD) are at significantly increased risk of colorectal cancer (CRC), principally resulting from the pro-neoplastic effects of chronic intestinal inflammation. Epidemiologic studies continue to highlight the increased risk of CRC in IBD. However, the incidence has declined over the past 30 years, attributed to both successful CRC-surveillance programs and improved control of mucosal inflammation. Risk factors that further increase the risk of IBD-related CRC include disease duration, extent and severity, the presence of inflammatory pseudopolyps, coexistent primary sclerosing cholangitis, and a family history of CRC. All major professional societies agree that IBD-CRC surveillance should occur more frequently than in the general population. Yet, guidelines and consensus statements differ on the surveillance schedule and preferred method of surveillance. Improved sensitivity to previously "invisible" flat dysplastic lesions using high definition and chromoendoscopy methods has resulted in many guidelines abandoning requirements for random untargeted biopsies of the colon. While colonic dysplasia remains a worrisome finding, and several clinical scenarios remain best addressed by total proctocolectomy due to concerns of synchronous undetected lesions and the unpredictable tempo of progression to malignancy, better detection techniques have also increased opportunities for endoscopic resection of dysplastic lesions that can be clearly delineated. Finally, the expanding armamentarium of medical options in IBD, including anti-tumor necrosis factor and anti-adhesion biologic therapies, have substantially improved our ability to control severe inflammation and likely reduce the risk of CRC over time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Indeed, comorbid psychological difficulties are associated with disease activity, flares, treatment response, and the necessity of surgical intervention [2,6,8,9,10,11,12,13,14,15].”
From Brief and Telehealth Acceptance and Commitment Therapy (ACT) Interventions for Stress in Inflammatory Bowel Disease (IBD): A Series of Single Case Experimental Design (SCED) Studies (2022) · cites this paper as [2]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.001 · Cited by 4,833
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,948
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135 · cited 1×
“33 However, when exposed to a proin fl ammatory cytokines, Treg inhibition of in fl ammation and proapoptotic effects are reduced.”
Kornbluth, A. A., & Sachar, D. B. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,032
Cairns, S. R., Scholefield, J. H., Steele, R. J., Dunlop, M. G., Thomas, H. J. W., Evans, D. G., Eaden, J., Rutter, M. D., Atkin, W. S., Saunders, B. P., et al. (2010) · Gut · doi:10.1136/gut.2009.179804 · Cited by 1,139
Intestinal Inflammation and Cancer
Ullman, T. A., & Itzkowitz, S. H. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.057 · Cited by 1,127
Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy
Schoen, R. E., Pinsky, P. F., Weissfeld, J. L., Yokochi, L. A., Church, T. R., Laiyemo, A. O., Bresalier, R. S., Andriole, G. L., Buys, S. S., Crawford, E. D., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114635 · Cited by 1,014
Jess, T., Rungoe, C., & Peyrin–Biroulet, L. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.01.010 · Cited by 958
Research works printed but not linked: 1
- Itzkowitz SH, Present DH; Crohn's and Colitis Foundation of America Colon Cancer in IBD Study Group. Inflamm Bowel Dis 2005;11(03):314-321
Cited by
Sorted by citations
Roda, G., Ng, S. C., Kotze, P. G., ARGOLLO, M. C., Panaccione, R., Spinelli, A., Kaser, A., Peyrin‐Biroulet, L., & Danese, S. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0156-2 · Cited by 1,111
Farvid, M. S., Sidahmed, E., Spence, N. D., Angua, K. M., ROSNER, B. A., & Barnett, J. B. (2021) · European Journal of Epidemiology · doi:10.1007/s10654-021-00741-9 · Cited by 473
Early-onset colorectal cancer: initial clues and current views
Hofseth, L. J., Hébert, J. R., Chanda, A., Chen, H., Love, B. L., Peña, M. M. O., Murphy, E. A., Sajish, M., Sheth, A., Buckhaults, P., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0253-4 · Cited by 448
Gut bacteria signaling to mitochondria in intestinal inflammation and cancer
Jackson, D. N., & Theiss, A. L. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1592421 · Cited by 312
Risk Factors for Colorectal Polyps and Cancer
Sninsky, J. A., Shore, B. M., Lupu, G. V., & Crockett, S. D. (2022) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2021.12.008 · Cited by 207
Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases
Bilski, J., Mazur-Biały, A. I., Wójcik-Grzybek, D., Surmiak, M., Magierowski, M., Śliwowski, Z., Pajdo, R., Kwiecień, S., Danielak, A., Ptak‐Belowska, A., et al. (2019) · Biomolecules · doi:10.3390/biom9120780 · Cited by 144
Extracellular vesicles and particles impact the systemic landscape of cancer
Lucotti, S., Kenific, C. M., Zhang, H., & Lyden, D. C. (2022) · The EMBO Journal · doi:10.15252/embj.2021109288 · Cited by 145
The impact of COVID-19 pandemic in the colorectal cancer prevention
Blanco, G. D. V., Calabrese, E., Biancone, L., Monteleone, G., & Paoluzi, O. A. (2020) · International Journal of Colorectal Disease · doi:10.1007/s00384-020-03635-6 · Cited by 116
Periostin in Allergy and Inflammation
Sonnenberg-Riethmacher, E., Miehe, M., & Riethmacher, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.722170 · Cited by 108
The Oral-Gut Axis: Periodontal Diseases and Gastrointestinal Disorders
Lam, G., Albarrak, H. A., McColl, C., Pizarro, A., Sanaka, H., Gomez-Nguyen, A., Cominelli, F., & da Silva, A. P. B. (2022) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac241 · Cited by 103
Therapeutic effect of baicalin on inflammatory bowel disease: A review
Wang, X., Xie, L., Long, J., Liu, K., Lu, J., Liang, Y., Cao, Y., Dai, X., & Li, X. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114749 · Cited by 94
Yu, M. R., Kim, H. J., & Park, H. R. (2020) · Cancers · doi:10.3390/cancers12102728 · Cited by 86
Li, X., Liu, Y., Wang, Y., Li, X., Liu, X., Guo, M., Tan, Y., Qin, X., Wang, X., & Jiang, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00710 · Cited by 76
Acosta, M. B., Molero, A., Artime, E., Díaz‐Cerezo, S., Lizán, L., de Paz, H. D., & Martín‐Arranz, M. D. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02473-6 · Cited by 74
Zhang, Y., Pu, W., Bousquenaud, M., Cattin, S., Zarić, J., Sun, L., & Rüegg, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.564674 · Cited by 75
Health Benefits of Dietary Fiber for the Management of Inflammatory Bowel Disease
Yusuf, K., Saha, S., & Umar, S. (2022) · Biomedicines · doi:10.3390/biomedicines10061242 · Cited by 76
Microbiota and Cancer: The Emerging Beneficial Role of Bifidobacteria in Cancer Immunotherapy
Longhi, G., van Sinderen, D., Ventura, M., & Turroni, F. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.575072 · Cited by 72
Hartwig, O., Boushehri, M. A. S., Shalaby, K. S., Loretz, B., Lamprecht, A., & Lehr, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113828 · Cited by 72
Zhang, Q., Zhang, F., Li, S., Liu, R., Jin, T., Dou, Y., Zhou, Z., & Zhang, J. (2019) · Theranostics · doi:10.7150/thno.34377 · Cited by 70
Roles of microRNAs in inflammatory bowel disease
Jung, H., Kim, J., Lee, K. H., Tizaoui, K., Terrazzino, S., Cargnin, S., Smith, L., Koyanagi, A., Jacob, L., Han, L., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59904 · Cited by 73
Curtis, J. R., Xavier Mariette, A., Gaujoux-Viala, C., Blauvelt, A., Kvien, T. K., Sandborn, W. J., Winthrop, K. L., Longueville, M. D., Huybrechts, I., & Bykerk, V. P. (2019) · RMD Open · doi:10.1136/rmdopen-2019-000942 · Cited by 64
Mitochondrial functions and rare diseases
Dard, L., Blanchard, W., Hubert, C., Lacombe, D., & Rossignol, R. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.100842 · Cited by 65
Jang, J. Y., Im, E., & Kim, N. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031954 · Cited by 59
Phuong, N. N. T., Palmieri, V., Adamczyk, A., Klopfleisch, R., Langhorst, J., Hansen, W., Westendorf, A. M., & Pastille, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669787 · Cited by 59
Machiels, K., Pozuelo, M., la Torre, A. M.-D., Xie, Z., Andreu, V., Sabino, J., Santiago, A., Campos, D., Wolthuis, A. M., D’Hoore, A., et al. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa081 · Cited by 59
Velikova, T. V., Miteva, L. D., Stanilov, N., Spassova, Z., & Stanilova, S. A. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i16.1912 · Cited by 58
Yang, C., Zhao, Y., Im, S., Nakatsu, C. H., Jones‐Hall, Y., & Jiang, Q. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108567 · Cited by 55
Fecal microbiota transplantation in non-communicable diseases: Recent advances and protocols
Hamamah, S., Gheorghita, R. E., Lobiuc, A., Sîrbu, I. O., & Covașă, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1060581 · Cited by 57
Tryptophan Metabolism, Regulatory T Cells, and Inflammatory Bowel Disease: A Mini Review
Ding, X., Bin, P., Wu, W., Chang, Y., & Zhu, G. (2020) · Mediators of Inflammation · doi:10.1155/2020/9706140 · Cited by 57
Prados, M. E., García‐Martín, A., Unciti-Broceta, J. D., Palomares, B., Collado, J. A., Minassi, A., Calzado, M. A., Appendino, G., & Muñóz, E. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0497-0 · Cited by 50
Gowrikumar, S., Ahmad, R., Uppada, S. B., Washington, M. K., Shi, C., Singh, A. B., & Dhawan, P. (2019) · Oncogene · doi:10.1038/s41388-019-0795-5 · Cited by 47
Host-microbiome protein-protein interactions capture disease-relevant pathways
Zhou, H., Beltrán, J. F., & Brito, I. (2022) · Genome biology · doi:10.1186/s13059-022-02643-9 · Cited by 46
Álvarez-Díaz, S., Preaudet, A., Samson, A. L., Nguyen, P. M., Fung, K. Y., Garnham, A. L., Alexander, W. S., Strasser, A., Ernst, M., Putoczki, T. L., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00673-z · Cited by 47
Eder, P., Łodyga, M., Gawron-Kiszka, M., Dobrowolska, A., Gonciarz, M., Hartleb, M., Kłopocka, M., Małecka-Wojciesko, E., Radwan, P., Reguła, J., et al. (2023) · Gastroenterology Review · doi:10.5114/pg.2023.125882 · Cited by 47
Hasegawa, T., Mizugaki, A., Inoue, Y., Kato, H., & Murakami, H. (2021) · Amino Acids · doi:10.1007/s00726-021-03001-y · Cited by 43
The Role of Inflammation in the Initiation and Progression of Myeloid Neoplasms
Balandrán, J. C., Lasry, A., & Aifantis, I. (2023) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-22-0176 · Cited by 44
Lee, Y., Liu, C., Lee, C., Zhang, R., Huang, C., & Yen, T. (2022) · Pathogens · doi:10.3390/pathogens11010084 · Cited by 40
Safety Evaluation and Anti-Inflammatory Efficacy of Lacticaseibacillus paracasei PS23
Li, C.-H., Chen, T.-Y., Wu, C.-C., Cheng, S.-H., Chang, M.-Y., Cheng, W.-H., Chiu, S., Chen, C., Tsai, Y.-C., Yang, D., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010724 · Cited by 38
Słoka, J., Madej, M., & Strzałka‐Mrozik, B. (2023) · Molecules · doi:10.3390/molecules28135081 · Cited by 38
Stronati, L., Palone, F., Negroni, A., Colantoni, E., Mancuso, A. B., Cucchiara, S., Cesi, V., Isoldi, S., & Vitali, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00939 · Cited by 38
Li, X., Xin, S., Zheng, X., Lou, L., Ye, S., Li, S., Wu, Q., Ding, Q., Ji, L., Nan, C., et al. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c02357 · Cited by 40
Garlic (Allium sativum L.) as an Ally in the Treatment of Inflammatory Bowel Diseases
Zugaro, S., Benedetti, E., & Caioni, G. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45010046 · Cited by 40
Research Progress on the Relationship Between Inflammation and Colorectal Cancer
Zhang, F., & Qiao, S. L. (2021) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12517 · Cited by 37
Bacteriophage-mediated manipulations of microbiota in gastrointestinal diseases
Haddad, L. E., Mendoza, J. F., & Jobin, C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1055427 · Cited by 43
Advancing human disease research with fish evolutionary mutant models
Beck, E. A., Healey, H. M., Small, C. M., Currey, M. C., Desvignes, T., Cresko, W. A., & Postlethwait, J. H. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.07.002 · Cited by 38
Marie, M. A., Sanderlin, E. J., Satturwar, S. P., Hong, H., Lertpiriyapong, K., Donthi, D., & Yang, L. V. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166288 · Cited by 37
Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation
Motofei, I. G. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.10.003 · Cited by 40
Precision Medicine in Inflammatory Bowel Disease: A Spotlight on Emerging Molecular Biomarkers
Meštrović, A., Perković, N., Božić, D., Kumrić, M., Vilović, M., & Božić, J. (2024) · Biomedicines · doi:10.3390/biomedicines12071520 · Cited by 36
MicroRNA signatures in the pathogenesis and therapy of inflammatory bowel disease
Ramadan, Y. N., Kamel, A. M., Medhat, M. A., & Hetta, . F. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01476-z · Cited by 36
To protect or adversely affect? The dichotomous role of the NLRP1 inflammasome in human disease
Tupik, J. D., Nagai-Singer, M. A., & Allen, I. C. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100858 · Cited by 35
Role of Prostaglandin E2 in the Progression of Gastrointestinal Cancer
Wilson, D. J., & DuBois, R. N. (2022) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-22-0038 · Cited by 35
Abu‐Freha, N., Cohen, B., Gordon, M. M., Weissmann, S., Kestenbaum, E. H., Vosko, S., Tailakh, M. A., Ben‐Shoshan, L., Cohen, D. L., & Shirin, H. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1225616 · Cited by 35
Jakszyn, P. G., Cayssials, V., Buckland, G., Perez‐Cornago, A., Weiderpass, E., Boeing, H., Bergmann, M. M., Vulcan, A., Ohlsson, B., Masala, G., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32870 · Cited by 35
Targeting Protein Synthesis in Colorectal Cancer
Schmidt, S., Denk, S., & Wiegering, A. (2020) · Cancers · doi:10.3390/cancers12051298 · Cited by 36
So, W. K. W., Chan, J. Y., Law, B. M. H., Choi, K. C., Ching, J. Y. L., Chan, K. L., Tang, R. S. Y., Chan, C. W. H., Wu, J. C. Y., & Tsui, S. K. (2021) · Nutrients · doi:10.3390/nu13020526 · Cited by 34
Dietary restrictions modulate the gut microbiota: Implications for health and disease
Schmidt, N. S., & Lorentz, A. (2021) · Nutrition Research · doi:10.1016/j.nutres.2021.03.001 · Cited by 34
Wang, T., Zheng, J., Dong, S., Ismael, M., Shan, Y., Wang, X., & Lü, X. (2022) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-022-09967-9 · Cited by 34
A synopsis of modern - day colorectal cancer: Where we stand
Ranasinghe, R., Mathai, M. L., & Zulli, A. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188699 · Cited by 35
the Italian Society of Colorectal Surgery (SICCR), Pellino, G., Keller, D. S., Sampietro, G. M., Annese, V., Carvello, M., Celentano, V., Coco, C., Colombo, F., Cracco, N., et al. (2020) · Techniques in Coloproctology · doi:10.1007/s10151-019-02145-0 · Cited by 32
Study Insights into Gastrointestinal Cancer through the Gut Microbiota
Kong, F., & Cai, Y. (2019) · BioMed Research International · doi:10.1155/2019/8721503 · Cited by 33
Intestinal dysbiosis and inflammation in cystic fibrosis impacts gut and multi-organ axes
Wrigley-Carr, H., van Dorst, J. M., & Ooi, C. Y. (2022) · Medicine in Microecology · doi:10.1016/j.medmic.2022.100057 · Cited by 31
Gut Microbiome–Colorectal Cancer Relationship
Yadav, D., Sainatham, C., Filippov, E., Kanagala, S. G., Ishaq, S. M., & Jayakrishnan, T. (2024) · Microorganisms · doi:10.3390/microorganisms12030484 · Cited by 33
The Emerging Role of Checkpoint Inhibition in Microsatellite Stable Colorectal Cancer
Hermel, D. J., & Sigal, D. S. (2019) · Journal of Personalized Medicine · doi:10.3390/jpm9010005 · Cited by 31
Villanacci, V., Bonetti, L. R., Caprioli, F., Saragoni, L., Salviato, T., Mescoli, C., Canavese, G., Manenti, S., Spada, E., Baron, L., et al. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.11.005 · Cited by 31
Haskey, N., Ye, J., Estaki, M., Verdugo‐Meza, A., Barnett, J. A., Yousefi, M., Birnie, B. W., Gruenheid, S., Ghosh, S., & Gibson, D. L. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2055441 · Cited by 31
Yu, L., Zhang, M., & Hou, J. (2022) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2022.2088247 · Cited by 32
Puzzo, M., Santo, M. D., Morelli, C., Leggio, A., Catalano, S., & Pasqua, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031313 · Cited by 31
Al-Badran, S. S. F., Grant, L., Campo, M. V., Inthagard, J., Pennel, K. A. F., Quinn, J. A., Konanahalli, P., Hayman, L., Horgan, P. G., McMillan, D., et al. (2020) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.193 · Cited by 29
A Crosstalk between Diet, Microbiome and microRNA in Epigenetic Regulation of Colorectal Cancer
Guz, M., Jeleniewicz, W., Malm, A., & Korona‐Głowniak, I. (2021) · Nutrients · doi:10.3390/nu13072428 · Cited by 31
Milanesi, E., Dobre, M., Bucuroiu, I. A., Herlea, V., Manuc, T. E., Salvi, A., Petro, G. D., Mănuc, M., & Becheanu, G. (2020) · Journal of Immunology Research · doi:10.1155/2020/4927120 · Cited by 28
Sheikh, A. A., Taube, J. H., & Greathouse, K. L. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab060 · Cited by 26
From inflammatory bowel disease to colorectal cancer: what’s the role of miRNAs?
Vaghari‐Tabari, M., Targhazeh, N., Moein, S., Qujeq, D., Alemi, F., Majidina, M., Younesi, S., Asemi, Z., & Yousefi, B. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02557-3 · Cited by 28
Islam, M. T., Martorell, M., González-Contreras, C., Villagrán, M., Mardones, L., Tynybekov, B., Docea, A. O., Razis, A. F. A., Modu, B., Călina, D. C., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1099380 · Cited by 28
Tian, S., Paudel, D., Hao, F., Neupane, R., Castro, R., Patterson, A. D., Tiwari, A. K., Prabhu, K. S., & Singh, V. (2023) · Cancer Reports · doi:10.1002/cnr2.1863 · Cited by 29
Imaging Inflammation and Infection in the Gastrointestinal Tract
Frickenstein, A. N., Jones, M. A., Behkam, B., & McNally, L. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010243 · Cited by 28
Loss of interleukin-17 receptor D promotes chronic inflammation-associated tumorigenesis
Girondel, C., Lévesque, K., Langlois, M., Pasquin, S., Saba-El-Leil, M. K., Rivard, N., Friesel, R. E., Servant, M. J., Gauchat, J., Lesage, S., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01540-4 · Cited by 27
Wang, L., Peng, F., Peng, C. Y., & Du, J. (2021) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x21500270 · Cited by 29
Maternal stress and early-onset colorectal cancer
Zhang, Q., Berger, F. G., Love, B. L., Banister, C. E., Murphy, E. A., & Hofseth, L. J. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.09.035 · Cited by 27
Sinopoulou, V., Nigam, G. B., Gordon, M. A., Ganeshan, M., Tokonyai, M. R., Dolwani, S., Iacucci, M., Rutter, M. D., Subramanian, V., Wilson, A., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.11.008 · Cited by 26
Lavelle, J., Storan, D., Eswara Murthy, V., De Dominicis, N., Mulcahy, H. E., & McHugh, L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102757 · Cited by 23
Effects of oral bovine lactoferrin on a mouse model of inflammation associated colon cancer
Tanaka, H., Gunasekaran, S., Saleh, D. M., Alexander, W. T., Alexander, D. B., Ohara, H., & Tsuda, H. (2020) · Biochemistry and Cell Biology · doi:10.1139/bcb-2020-0087 · Cited by 25
Tang, S., Zhang, Z., Oakley, R., Li, W., He, W.-J., Xu, X.-J., Ji, M., Xu, Q., Chen, L., Wellman, A. S., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.151815 · Cited by 18
Novel Role of Ghrelin Receptor in Gut Dysbiosis and Experimental Colitis in Aging
Noh, J. Y., Wu, C., DeLuca, J. A. A., Devaraj, S., Jayaraman, A., Alaniz, R. C., Tan, X., Allred, C. D., & Sun, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042219 · Cited by 25
Inflammatory polyps occur more frequently in inflammatory bowel disease than other colitis patients
Ashktorab, H., Brim, H., Hassan, S., Nouraie, M. S., Gebreselassie, A., Laiyemo, A. O., Kibreab, A., Aduli, F., Latella, G., Brant, S. R., et al. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01279-y · Cited by 25
Liu, K. Y., Wang, Q., Nakatsu, C. H., Jones‐Hall, Y., & Jiang, Q. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175656 · Cited by 24
Maryńczak, K., Włodarczyk, J., Sabatowska, Z., Dziki, A. J., Dziki, Ł. A., & Włodarczyk, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030866 · Cited by 23
Liu, Z., Georgakopoulos‐Soares, I., Ahituv, N., & Wong, K. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121413 · Cited by 23
Primary sclerosing cholangitis and inflammatory bowel disease: Intestine–liver interrelation
Paulina Núñez, F., Rodrigo Quera, P., & Gomollón, F. (2019) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2019.02.030 · Cited by 22
Bugajewski, M., Angerhoefer, N., Pączek, L., & Kaleta, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073320 · Cited by 21
Altaf‐Ul‐Amin, M., Karim, M. B., Hu, P., Ono, N., & Kanaya, S. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-0660-y · Cited by 20
Kim, H., Jee, S., Kim, Y., Sim, J., Bang, S., Son, H., Park, H., Myung, J. K., Ko, Y. H., & Paik, S. S. (2021) · Diagnostics · doi:10.3390/diagnostics11040668 · Cited by 20
Colorectal Cancer Risk Is Impacted by Sex and Type of Surgery After Bariatric Surgery
Hussan, H., Akinyeye, S. A., Mihaylova, M. M., McLaughlin, E. M., Chiang, C., Clinton, S. K., & Lieberman, D. A. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06155-0 · Cited by 20
Components of the Fiber Diet in the Prevention and Treatment of IBD—An Update
Ferenc, K., Jarmakiewicz-Czaja, S., & Filip, R. (2022) · Nutrients · doi:10.3390/nu15010162 · Cited by 21
Paulina Núñez, F., Quera, R., & Gomollón, F. (2019) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2019.02.004 · Cited by 20
The Role of MicroRNAs upon Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease
Boros, É., & Nagy, I. (2019) · Cells · doi:10.3390/cells8111461 · Cited by 21
Sutton, S. S., Magagnoli, J., Cummings, T. H., & Hardin, J. W. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000173 · Cited by 20
Wang, D., Zhu, X., Tang, X., Li, H., Yizhen, X., & Chen, D. (2020) · Journal of Food Science · doi:10.1111/1750-3841.15134 · Cited by 19
Expression profile of serum LncRNA THRIL and MiR-125b in inflammatory bowel disease
Elamir, A. M., Shaker, O. G., Kamal, M., Khalefa, A. A., Abdelwahed, M. Y., Reheem, F. A. E., Ahmed, T. I., Hassan, E. A., & Ayoub, S. E. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275267 · Cited by 19
Zhang, S., Cao, L., Li, Z., & Qu, D. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.02.045 · Cited by 20
Sattar, R. S. A., Sumi, M. P., Nimisha, Apurva, A., Kumar, A., Sharma, A. K., Ahmad, E., Ali, A., Mahajan, B., & Saluja, S. S. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110080 · Cited by 19
Metadata
- Authors
- Higgins, P., & Stidham, R.
- Affiliations
- University of Michigan (US)
- Venue
- Clinics in Colon and Rectal Surgery
- Publisher
- Georg Thieme Verlag KG
- Published
- 2018-04-01
- Volume
- 31
- Issue
- 03
- Pages
- 168-178
- ISSN
- 1521-5741 (ISSN-L)
- 1531-0043
- 1530-9681
- PMC
- PMC5929884
- OpenAlex
- W2795176771
- Cited by
- 295
- References
- 93
- Citations by year
- 2026: 16 · 2025: 38 · 2024: 37 · 2023: 46 · 2022: 60 · 2021: 42 · 2020: 31 · 2019: 22 · 2018: 2
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinics in Colon and Rectal Surgery (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (K23DK101687)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- inflammatory bowel disease, colorectal cancer, IBD-associated colorectal cancer, chronic intestinal inflammation, colorectal cancer surveillance, inflammatory pseudopolyps, primary sclerosing cholangitis, colonic dysplasia, chromoendoscopy, high-definition endoscopy, endoscopic resection, total proctocolectomy, anti-TNF therapy, disease duration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
